The untapped potential of ascites in ovarian cancer research and treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The untapped potential of ascites in ovarian cancer research and treatment
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-08
DOI
10.1038/s41416-020-0875-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
- (2019) Edith Emmings et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Palliation of malignant ascites
- (2019) Caitlin Hodge et al. JOURNAL OF SURGICAL ONCOLOGY
- Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer
- (2019) Ingrid Lai et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base
- (2019) E. Canaz et al. GYNECOLOGIC ONCOLOGY
- Ascitic IL‐10 concentration predicts prognosis of the patients undergoing Cell‐Free and Concentrated Ascites Reinfusion Therapy (CART)
- (2019) Tetsuya Ito et al. THERAPEUTIC APHERESIS AND DIALYSIS
- High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids
- (2019) Frank Antony et al. OncoImmunology
- The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
- (2019) Bregenzer et al. Cancers
- Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy
- (2019) Chee Khoon Lee et al. EUROPEAN JOURNAL OF CANCER
- Who are the long-term survivors of high grade serous ovarian cancer?
- (2018) Claire Hoppenot et al. GYNECOLOGIC ONCOLOGY
- Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study
- (2018) C.A. Hamilton et al. GYNECOLOGIC ONCOLOGY
- STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
- (2018) Federica Laudisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
- (2018) Jennifer Pasquier et al. Molecular Cancer
- Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
- (2018) Sara Al Habyan et al. ONCOGENE
- Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites—Correlation of tissue microarray and cytology microarray
- (2018) Laszlo Toth et al. PATHOLOGY RESEARCH AND PRACTICE
- Characterizing the Cancer Genome in Blood
- (2018) Sarah-Jane Dawson Cold Spring Harbor Perspectives in Medicine
- Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells
- (2018) Sonja Lieber et al. OncoImmunology
- Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
- (2018) Sungsik Kim et al. Scientific Reports
- Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006–2015
- (2018) Jens Krugmann et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
- (2018) Soochi Kim et al. BMC CANCER
- Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models
- (2018) Daniel Newsted et al. OncoImmunology
- Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study
- (2017) J. Brian Szender et al. GYNECOLOGIC ONCOLOGY
- Malignant ascites determine the transmesothelial invasion of ovarian cancer cells
- (2017) Justyna Mikuła-Pietrasik et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
- (2017) Hatim Husain et al. MOLECULAR CANCER THERAPEUTICS
- Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses
- (2017) Trillitye Paullin et al. PLoS One
- STAT3: a crucial target for ovarian cancer stem cells that inhibits WNT signaling through a novel epigenetic mechanism
- (2017) Mijung Kwon et al. Translational Cancer Research
- Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
- (2017) Sajad Dar et al. Scientific Reports
- Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
- (2016) G. J. S. Rustin et al. ANNALS OF ONCOLOGY
- Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
- (2016) Soochi Kim et al. CANCER SCIENCE
- Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions
- (2016) Isabelle Matte et al. CLINICAL & EXPERIMENTAL METASTASIS
- Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
- (2016) Jacek P. Grabowski et al. GYNECOLOGIC ONCOLOGY
- Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
- (2016) U Saini et al. ONCOGENE
- Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
- (2016) Carman K. M. Ip et al. Scientific Reports
- Tumor microenvironment: Sanctuary of the devil
- (2015) Lanlan Hui et al. CANCER LETTERS
- TGFβ signaling regulates epithelial–mesenchymal plasticity in ovarian cancer ascites-derived spheroids
- (2015) Samah Rafehi et al. ENDOCRINE-RELATED CANCER
- Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
- (2015) Ernest K. Amankwah et al. GENETIC EPIDEMIOLOGY
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
- (2015) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer
- (2015) Nonna Kolomeyevskaya et al. GYNECOLOGIC ONCOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- In Vitro Microtumors Provide a Physiologically Predictive Tool for Breast Cancer Therapeutic Screening
- (2015) Gabriel Benton et al. PLoS One
- Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
- (2015) Elena Pereira et al. PLoS One
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer
- (2014) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of Australian women with invasive epithelial ovarian cancer: a population-based study
- (2014) Satyamurthy Anuradha et al. MEDICAL JOURNAL OF AUSTRALIA
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Peritoneal carcinomatosis
- (2013) Federico Coccolini WORLD JOURNAL OF GASTROENTEROLOGY
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5
- (2012) Daniel Herr et al. GYNECOLOGIC ONCOLOGY
- Malignant ascites: pathophysiology and treatment
- (2012) Emanuel Cavazzoni et al. International Journal of Clinical Oncology
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
- (2012) Nadzeya Goncharenko-Khaider et al. Molecular Cancer
- Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
- (2012) Ardian Latifi et al. PLoS One
- Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
- (2012) Denis Lane et al. Journal of Ovarian Research
- Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed
- (2011) G. J. S. Rustin ANNALS OF ONCOLOGY
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
- (2011) Denis Lane et al. BMC CANCER
- Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
- (2011) Walter H Gotlieb et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
- Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
- (2009) C William Helm et al. Journal of Ovarian Research
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search